Form 4: Fulgent Genetics President Sells Shares for Tax Coverage
Statement of Changes in Beneficial Ownership
Fulgent Genetics President and COO Jian Xie sold 1,201 shares of common stock to satisfy tax withholding obligations related to restricted stock unit vesting.
Summary
- Jian Xie, President and COO of Fulgent Genetics, Inc., sold 1,201 shares of common stock on May 27, 2026.
- The shares were sold at a weighted-average price of $17.60 per share.
- The transaction was executed to cover tax withholding obligations resulting from the vesting of restricted stock units granted on February 26, 2024.
- Following the transaction, the reporting person maintains direct ownership of 369,751 shares and indirect ownership of 220,816 shares held by The Hsieh Family Dynasty Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale is purely administrative and related to tax compliance rather than a strategic divestment.
Positives
- The sale was non-discretionary, specifically intended to satisfy tax obligations rather than reflecting a change in management sentiment regarding company prospects.
Negatives
- Reduction in direct equity holdings by a key executive.
Risks
- Market perception of insider selling, even when related to tax obligations, can occasionally create short-term downward pressure on stock price.
Future Outlook
No forward-looking guidance or strategic outlook was provided in this filing.
Industry Context
StockSavvy.ai notes that routine insider selling for tax withholding purposes is a standard corporate governance practice and typically does not signal a lack of confidence in the company's long-term strategic direction.
Comparison to Industry Standards
- The transaction aligns with standard executive compensation practices where equity-based awards are liquidated to cover mandatory tax liabilities upon vesting.
Related Party Transactions
- The reporting person maintains an interest in The Hsieh Family Dynasty Trust, which holds 220,816 shares of the issuer.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was small in volume and for tax compliance purposes.
Key Dates
| Date | Description |
|---|---|
| 2010-01-27 | Date of establishment for The Hsieh Family Dynasty Trust. |
| 2024-02-26 | Grant date of the restricted stock units that triggered the tax withholding. |
| 2026-05-27 | Date of the reported stock sale transaction. |
| 2026-05-28 | Date of filing for the Form 4. |
Keywords
Fulgent Genetics, FLGT, Insider Trading, Form 4, Executive Compensation, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.